Gynecologic Oncology

Survivorship and Monitoring Your Health

At a Glance

After endometrial cancer treatment, follow-up is tailored to your cancer risk and treatment history, with visits usually every 3–6 months for the first two years. Report new symptoms promptly, and seek emergency care for severe bleeding or possible lung-clot symptoms.

Life after endometrial cancer treatment is a transition that involves both physical recovery and long-term monitoring. While most patients feel a sense of relief when active treatment ends, it is normal to experience lasting effects on your body, energy levels, and sexual health. Understanding what to expect—and which symptoms require medical attention—empowers you to take an active role in your survivorship.

Recognizing Red Flags and Emergencies

Most recoveries are straightforward, but some symptoms require medical triage. Knowing the difference between an emergency and an urgent clinic visit is crucial.

Go to the ER or Call Emergency Services Immediately for:

Signs of a Blood Clot in the Lung (Pulmonary Embolism): Sudden shortness of breath, sharp chest pain that worsens when you breathe in, coughing up blood, or fainting ^[1]^[2].
Severe Bleeding: Heavy vaginal bleeding that soaks through a pad in an hour or passing large clots ^[3]^[4].

Call for Same-Day Urgent Medical Evaluation for:

Signs of a Blood Clot in the Leg (Deep Vein Thrombosis): New swelling in one leg (usually not both), along with pain, tenderness, or redness in the calf or thigh ^[5]^[2]. Do not ignore leg swelling, but if you have no chest pain or shortness of breath, call your doctor for immediate evaluation rather than calling 911.

Call Your Doctor Promptly for:

New or persistent pelvic or abdominal pain ^[6].
Unexplained weight loss or loss of appetite ^[7].
A chronic cough or new shortness of breath ^[7].
Changes in your bowel or bladder habits that do not improve ^[8].

Managing Long-Term Quality of Life

Different treatments can leave different “footprints” on your body.

Surgical Menopause: If your ovaries were removed and you had not yet reached menopause, you will experience an abrupt drop in hormones. This can cause intense hot flashes, night sweats, mood changes, and long-term concerns about bone and heart health ^[9]^[10]. Discuss options for symptom relief—both non-hormonal and hormonal—based on your specific cancer risk and history.
Lymphedema: If you had a full lymph node removal (lymphadenectomy), you are at higher risk for lymphedema—a chronic swelling in the legs or pelvic area caused by a backup of lymph fluid ^[11]^[12]. Sentinel node mapping significantly reduces this risk, but it can still occur ^[12]^[13]. Lymphedema is not always painful; it may be mild and is highly treatable if caught early. Report any new heaviness or swelling to your doctor for an early referral to a physical therapist.
Sexual and Vaginal Health: Radiation therapy, especially External Beam Radiation (EBRT) and brachytherapy, can cause the vagina to become shorter, narrower, and less elastic (stenosis) ^[14]^[15]. Vaginal dryness and pain during intercourse are common.
- Vaginal Dilators: To prevent the vaginal walls from sticking together or narrowing, your doctor may recommend regular use of a vaginal dilator. This must be started on a clinician-specific schedule after surgical or radiation healing is complete to avoid pain or injury ^[16].
- Lubricants: Using water-based or silicone-based lubricants and vaginal moisturizers can help manage dryness and discomfort ^[15].
Bowel and Bladder Changes: EBRT can cause lasting changes, including a frequent or urgent need to use the bathroom, or occasional fecal leakage ^[8]^[17].

Your Surveillance Schedule

The goal of follow-up care is to detect any return of the cancer (recurrence) as early as possible. Most recurrences happen within the first three years after treatment ^[7].

Your specific schedule depends heavily on your risk group, the treatments you received, and your symptoms, but a typical plan often includes:

Years 1–2: Follow-up visits every 3 to 6 months ^[7].
Years 3–5: Follow-up visits every 6 to 12 months ^[7].
After 5 Years: Annual visits ^[7].

During these visits, your doctor will perform a physical and pelvic exam to look for any signs of recurrence ^[18]^[19]. Routine imaging (like CT or PET scans) is generally not recommended for asymptomatic patients with low- or intermediate-risk disease. Imaging is appropriately used for high-risk disease, advanced stages, or if you develop new symptoms ^[6]. Similarly, routine vaginal cytology (“Pap” smears) is not generally recommended after a total hysterectomy unless you have a history of high-grade cervical disease ^[18].

The most important part of your follow-up is reporting any new or unusual symptoms to your care team immediately without waiting for your next scheduled appointment ^[18]^[20]. Consider asking for a written survivorship care plan that outlines your specific follow-up needs.

Common questions in this guide

How often are follow-up visits scheduled after endometrial cancer treatment?

The schedule depends on your cancer risk group, treatment history, and symptoms. A common pattern is visits every 3 to 6 months during years 1 and 2, every 6 to 12 months during years 3 through 5, and yearly visits afterward. Contact your care team sooner if you develop new or unusual symptoms.

Which symptoms after endometrial cancer treatment require emergency care?

Sudden shortness of breath, sharp chest pain that worsens with breathing, coughing up blood, or fainting may signal a blood clot in the lung and requires emergency help. Heavy vaginal bleeding that soaks a pad within an hour or large blood clots also requires immediate evaluation. New swelling, pain, or redness in one leg without chest symptoms should be evaluated by your doctor the same day.

Do I need routine CT, PET, or Pap tests after endometrial cancer?

Routine CT or PET scans are generally not recommended for people without symptoms who have low- or intermediate-risk disease. Imaging may be appropriate for high-risk or advanced disease or when new symptoms develop. After a total hysterectomy, routine vaginal cytology is usually not needed unless there is a history of high-grade cervical disease.

What long-term side effects should I watch for after endometrial cancer treatment?

Removing the ovaries before natural menopause can cause hot flashes, night sweats, mood changes, and longer-term bone and heart health concerns. Lymph node removal can lead to lymphedema, while pelvic radiation can cause vaginal narrowing, dryness, pain, and bowel or bladder changes. Report new swelling, persistent pain, or worsening symptoms to your care team.

When should I start using vaginal dilators after radiation or surgery?

Use a vaginal dilator only on the schedule recommended by your clinician and after surgical or radiation healing is complete. Starting too soon can cause pain or injury, while regular use may help prevent narrowing of the vagina. Water-based or silicone-based lubricants and vaginal moisturizers may also reduce dryness and discomfort.

Can menopause symptoms after endometrial cancer be treated?

Yes, non-hormonal and hormonal options may be considered, but the safest choice depends on your cancer risk, treatment history, and overall health. If your ovaries were removed, ask your oncology or gynecology team how to monitor and protect bone and heart health. Do not start hormone treatment without discussing it with your clinician.

Get notified when new evidence is published on endometrial cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

Follow-up is usually every 3–6 months during years 1–2, every 6–12 months during years 3–5, and annually afterward, but your schedule should be individualized.
Sudden breathlessness, chest pain, coughing up blood, fainting, or severe vaginal bleeding requires emergency care; new one-sided leg swelling needs same-day evaluation.
Routine imaging is generally not needed for asymptomatic people with low- or intermediate-risk disease, but it may be used for high-risk disease, advanced stages, or new symptoms.
Long-term effects may include surgical menopause, lymphedema, vaginal dryness or narrowing, painful sex, and bowel or bladder changes.
Vaginal dilators should be started only after healing and according to a clinician’s schedule, while lubricants and moisturizers may ease dryness.

References (20)

1
Management of Deep Vein Thrombosis (DVT) Prophylaxis in Trauma Patients.
Paydar S, Sabetian G, Khalili H, et al.
Bulletin of emergency and trauma 2016; (4(1)):1-7.
PMID: 27162921
2
"The Great Masquerader": An Interesting Case Series of Pulmonary Thromboembolism.
Sritharan SB, Raj CP, Ta V, et al.
Cureus 2022; (14(12)):e32330 doi:10.7759/cureus.32330.
PMID: 36632266
3
Management of Iron Deficiency Anemia.
Jimenez K, Kulnigg-Dabsch S, Gasche C
Gastroenterology & hepatology 2015; (11(4)):241-50.
PMID: 27099596
4
An atypical presentation of endometrial cancer as angina secondary to critically low hemoglobin and iron deficiency associated pancytopenia: A case report.
Crawford G, Bahabri A, P'ng S
Case reports in women's health 2023; (38()):e00509 doi:10.1016/j.crwh.2023.e00509.
PMID: 37180555
5
Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy.
Yao M, Ma J, Wu D, et al.
Frontiers in immunology 2023; (14()):1198952 doi:10.3389/fimmu.2023.1198952.
PMID: 37680629
6
ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.
, Reinhold C, Ueno Y, et al.
Journal of the American College of Radiology : JACR 2020; (17(11S)):S472-S486 doi:10.1016/j.jacr.2020.09.001.
PMID: 33153558
7
Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S, Ouldamer L, Lavoue V, et al.
Gynecologic oncology 2017; (144(1)):107-112 doi:10.1016/j.ygyno.2016.10.025.
PMID: 27789083
8
Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.
de Boer SM, Nout RA, Jürgenliemk-Schulz IM, et al.
International journal of radiation oncology, biology, physics 2015; (93(4)):797-809.
PMID: 26530748
9
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, et al.
Radiation oncology (London, England) 2023; (18(1)):5 doi:10.1186/s13014-023-02198-4.
PMID: 36624483
10
Quality of life and climacteric symptoms in women with endometrial cancer: examining the impact of lower limb lymphedema.
Li CC, Chang TC, Chang CW, et al.
Journal of patient-reported outcomes 2025; (9(1)):66 doi:10.1186/s41687-025-00895-0.
PMID: 40512268
11
Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.
Wedin M, Stålberg K, Marcickiewicz J, et al.
Gynecologic oncology 2020; (159(1)):201-208 doi:10.1016/j.ygyno.2020.07.014.
PMID: 32763108
12
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
Geppert B, Lönnerfors C, Bollino M, Persson J
Gynecologic oncology 2018; (148(3)):491-498 doi:10.1016/j.ygyno.2017.12.017.
PMID: 29273307
13
Sentinel node navigation surgery in cervical and endometrial cancer: a review.
Niikura H, Tsuji K, Tokunaga H, et al.
Japanese journal of clinical oncology 2019; (49(6)):495-500 doi:10.1093/jjco/hyz062.
PMID: 31070770
14
Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results.
Delishaj D, Barcellini A, D'Amico R, et al.
Journal of contemporary brachytherapy 2018; (10(6)):559-566 doi:10.5114/jcb.2018.79713.
PMID: 30662479
15
Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery.
Gao H, Xiao M, Bai H, Zhang Z
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017; (27(3)):608-612 doi:10.1097/IGC.0000000000000905.
PMID: 28129240
16
Impact of Vaginal Dilator Use and 68 Gy EQD2(α/β=3) Dose Constraint on Vaginal Complications in External Beam Irradiation Followed by Brachytherapy in Post-Operative Endometrial Cancer.
Noorian F, Abellana R, Zhang Y, et al.
Journal of personalized medicine 2024; (14(8)) doi:10.3390/jpm14080838.
PMID: 39202029
17
Prognostic factors for long-term quality of life after adjuvant radiotherapy in women with endometrial cancer.
Foerster R, Schnetzke L, Bruckner T, et al.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 2016; (192(12)):895-904 doi:10.1007/s00066-016-1037-1.
PMID: 27605238
18
Patterns and utility of routine surveillance in high grade endometrial cancer.
Hunn J, Tenney ME, Tergas AI, et al.
Gynecologic oncology 2015; (137(3)):485-9.
PMID: 25838164
19
Detection of recurrence in early stage endometrial cancer - the role of symptoms and routine follow-up.
Jeppesen MM, Mogensen O, Hansen DG, et al.
Acta oncologica (Stockholm, Sweden) 2017; (56(2)):262-269 doi:10.1080/0284186X.2016.1267396.
PMID: 28080157
20
Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer.
Beaver K, Martin-Hirsch P, Williamson S, Kyrgiou M
European journal of oncology nursing : the official journal of European Oncology Nursing Society 2020; (44()):101704 doi:10.1016/j.ejon.2019.101704.
PMID: 31812918

This survivorship information is for education and does not replace individualized medical advice. Your oncology team should set your follow-up schedule and guide treatment for symptoms or late effects.

Guide Contents